(Q50262786)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Tau protein and beta-amyloid(1-42) CSF levels in different phenotypes of Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

ChEBI release 2020-05-28

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

David Stejskal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Hana Přikrylová Vranová

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Petr Hluštík

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Martin Nevrlý

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jana Zapletalová

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Radko Obereigneru

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Petr Kaňovský

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

4 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neural Transmission

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

353-362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00702-011-0708-4

12 February 2020

exact match

0 references

cites work

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Dementia and survival in Parkinson disease: a 12-year population study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Are the frontal lobes implicated in "planning" functions? Interpreting data from the Tower of Hanoi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Neurodegenerative tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Does motor subtype influence neurocognitive performance in Parkinson's disease without dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

The neuropathologic basis of different clinical subgroups of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Parkinsonism, Lrrk2 G2019S, and tau neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Course in Parkinson disease subtypes: A 39-year clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

A clinico-pathological study of subtypes in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

The identification of Parkinson's disease subtypes using cluster analysis: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Clinical subtypes of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

How do patients with parkinsonism present? A clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0708-4

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

21 January 2018

1 reference

12 December 2020

Apolipoprotein E epsilon4 allele frequency is increased in Parkinson's disease only with co-existing Alzheimer pathology.

1 reference

12 December 2020

Detection of protein biomarkers using high-throughput immunoblotting following focal ischemic or penetrating ballistic-like brain injuries in rats

1 reference

12 December 2020

Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury.

1 reference

12 December 2020

Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients

1 reference

12 December 2020

Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer.

1 reference

12 December 2020

Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury.

1 reference

12 December 2020

CSF markers of neurodegeneration in Parkinson's disease

1 reference

12 December 2020

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

1 reference

12 December 2020

Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro

1 reference

12 December 2020

Applications of new laboratory marker assays in neurological diagnoses - a pilot study

1 reference

12 December 2020

10.1007/S00702-011-0708-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892760%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference